Acute attack of hereditary angioedema
Also known as: Acute attacks Hereditary angioedema / Acute attacks of hereditary angioedema / Hereditary angioedema attack / Hereditary angioedema C1 inhibitor deficiency / Hereditary angioedema / Hereditary angioneurotic edema (disorder) / Angioedemas, Hereditary / C1 esterase inhibitor deficiency
Drug | Drug Name | Drug Description |
---|---|---|
DB15982 | Berotralstat | An inhibitor of plasma kallikrein used for prophylaxis of angioedema attacks in patients with hereditary angioedema. |
DB09228 | Conestat alfa | A recombinant C1INH used for the treatment of acute attacks of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency in adults. |
DB05311 | Ecallantide | A kallikrein inhibitor used to prevent and treat acute attacks caused by Hereditary Angioedema (HAE). |
DB06404 | Human C1-esterase inhibitor | A C1 inhibitor used to prevent angioedema attacks associated with hereditary angioedema. |
DB06196 | Icatibant | A bradykinin B2 receptor antagonist used to treat acute episodes of swelling and inflammation associated with hereditary angioedema (HAE). |
DB14597 | Lanadelumab | A monoclonal antibody targeted against kallikrein which is used to treat attacks of hereditary angioedema. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB18303 | Deucrictibant | 2 | Active Not Recruiting | 1 |
DB18303 | Deucrictibant | 2 | Completed | 1 |
DB18303 | Deucrictibant | 2 / 3 | Recruiting | 1 |